Helius Medical Technologies, Inc. (HSDT)

HSDT Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	0.39	0.48	0.61	0.78	0.49	0.66
Other Revenue	0.04	0.04	0.04	0.01	0.03	-
Revenue	0.43	0.52	0.64	0.79	0.52	0.66
Revenue Growth (YoY)	-35.03%	-19.25%	-18.17%	50.77%	-21.03%	-55.82%
Cost of Revenue	0.58	0.58	0.58	0.46	0.3	0.39
Gross Profit	-0.15	-0.06	0.06	0.32	0.22	0.27
Selling, General & Admin	10.48	10.12	9.27	10.64	12.18	9.53
Research & Development	3.82	3.66	2.94	4.26	5.99	4.58
Operating Expenses	14.31	13.8	12.33	15.08	18.37	14.48
Operating Income	-14.46	-13.86	-12.27	-14.76	-18.14	-14.2
Interest Expense	-0.02	-0.02	-	-0.93	-	-
Interest & Investment Income	0.02	-	0.26	0.1	-	-
Currency Exchange Gain (Loss)	-0.67	-1.01	0.28	-0.76	0.01	0.19
Other Non Operating Income (Expenses)	2.1	3.18	3.05	3.03	-	0.07
EBT Excluding Unusual Items	-13.02	-11.7	-8.69	-13.32	-18.13	-13.95
Impairment of Goodwill	-	-	-	-0.76	-	-
Asset Writedown	-0.04	-0.04	-0.16	-	-	-0.18
Pretax Income	-13.06	-11.74	-8.85	-14.07	-18.13	-14.13
Net Income	-13.06	-11.74	-8.85	-14.07	-18.13	-14.13
Net Income to Common	-13.06	-11.74	-8.85	-14.07	-18.13	-14.13
Free Cash Flow	-11.58	-11.05	-10.45	-14.33	-13.44	-11.8
Gross Margin	-33.64%	-11.92%	9.47%	41.17%	42.91%	41.30%
Operating Margin	-3331.34%	-2665.96%	-1905.12%	-1875.35%	-3475.48%	-2148.56%
Profit Margin	-3010.14%	-2258.08%	-1374.22%	-1788.06%	-3473.56%	-2137.67%
Free Cash Flow Margin	-2667.28%	-2124.23%	-1621.89%	-1820.46%	-2575.10%	-1785.32%
EBITDA	-14.41	-13.8	-12.11	-14.5	-17.83	-13.72
D&A For EBITDA	0.05	0.06	0.16	0.26	0.31	0.48
EBIT	-14.46	-13.86	-12.27	-14.76	-18.14	-14.2
Revenue as Reported	0.43	0.52	0.64	0.79	0.52	0.66
Advertising Expenses	-	0.65	0.67	-	-	-

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q